tiprankstipranks
Vertex Pharmaceuticals Inc. (DE:VX1)
NASDAQ:VX1
Germany Market
VX1
Vertex Pharmaceuticals
RESEARCH TOOLSreports

Vertex Pharmaceuticals (VX1) Stock News & Sentiment

23 Followers
Vertex Pharmaceuticals: Solid CF Franchise and Emerging Pipeline Support Buy Rating and Premium Valuation
Premium
Ratings
Vertex Pharmaceuticals: Solid CF Franchise and Emerging Pipeline Support Buy Rating and Premium Valuation
24h ago
VRTX
Anthropic Finalizes $400 Million Takeover of AI Startup Coefficient Bio
Premium
Market News
Anthropic Finalizes $400 Million Takeover of AI Startup Coefficient Bio
13d ago
NVO
SNY
Vertex Advances FDA Filing for IgA Nephropathy Therapy
Premium
Company Announcements
Vertex Advances FDA Filing for IgA Nephropathy Therapy
15d ago
8K
VRTX
Vertex’s VX-407 Contraceptive Interaction Study Reaches Completion: What Investors Should Watch
Premium
Company Announcements
Vertex’s VX-407 Contraceptive Interaction Study Reaches Completion: What Investors Should Watch
17d ago
VRTX
Vertex Pharmaceuticals: Resilient CF Franchise and Advancing Pipeline Support Buy Rating Despite Label Headwinds
Premium
Ratings
Vertex Pharmaceuticals: Resilient CF Franchise and Advancing Pipeline Support Buy Rating Despite Label Headwinds
17d ago
VRTX
Vertex’s VX-407 Kidney Study Completion: What Phase 1 Progress Means For VRTX Investors
Premium
Company Announcements
Vertex’s VX-407 Kidney Study Completion: What Phase 1 Progress Means For VRTX Investors
20d ago
VRTX
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts
Premium
Weekend Updates
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts
26d ago
STZ
TTD
More DE:VX1 News >

VX1 News on the Web

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Vertex Pharmaceuticals (VRTX)
TipRanks News
Neutral
Morgan Stanley Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)
TipRanks News
Bullish
Vertex Pharmaceuticals: Solid CF Franchise and Emerging Pipeline Support Buy Rating and Premium Valuation
TipRanks News
Bullish
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.
The Motley Fool
Bullish
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know
Zacks
Neutral
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
TipRanks News
Bullish
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Zacks
Bullish
Vertex Pharmaceuticals (VRTX) Receives a Buy from Morgan Stanley
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
DE:VX1
Sector Average
Media Buzz
This Week9 articles
Weekly Average10.25 articles
News Sentiment
This Week99%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:VX1’s Media Buzz Sentiment?
9 articles about DE:VX1 were published this week. In an average week, 10.25 articles are published.
    What is DE:VX1’s weekly average amount of articles?
    In an average week, 10.25 articles about DE:VX1 are published.
      What is DE:VX1’s News Sentiment?
      99% of articles about DE:VX1 were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        ALLOAllogene Therapeutics
        TXTMProText Mobility
        REPLReplimune Group
        RVMDRevolution Medicines
        HVOOpen Orphan Plc
        Showing the stocks with the most bullish news sentiment over the past week